A study sponsor supports the development of the study design and protocol and is responsible for the conduct of the trials and financial support of the trials.
Zambon S.p.A. is the sponsor of the BOSTON-1 and BOSTON-2 trials. Zambon is an Italian family-owned multinational chemical and pharmaceutical company founded in 1906 with over 2,800 employees worldwide and products commercialized in 87 countries. Zambon is committed to enhancing the lives of patients by identifying, developing and delivering innovative healthcare solutions. More information is available at www.Zambon.com.